Kif1aorg Inc is located in New York, NY. The organization was established in 2017. According to its NTEE Classification (F01) the organization is classified as: Alliances & Advocacy, under the broad grouping of Mental Health & Crisis Intervention and related organizations. As of 12/2023, Kif1aorg Inc employed 2 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Kif1aorg Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Kif1aorg Inc generated $229.5k in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 6.4% each year. All expenses for the organization totaled $423.7k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
KIF1A.ORG IS A GLOBAL COMMUNITY DEDICATED TO IMPROVING THE LIVES OF THOSE AFFECTED BY KIF1A-ASSOCIATED NEUROLOGICAL DISORDERS AND ACCELERATING RESEARCH TO FIND A CURE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH AND DEVELOPMENT - KIF1A.ORG POWERS COLLABORATIVE AND TRANSLATIONAL RESEARCH TO RAPIDLY DISCOVER TREATMENT FOR KAND. KIF1A.ORG MANAGES SEVERAL PROGRAMS TO DE-RISK AND ACCELERATE THERAPEUTIC DEVELOPMENT, INCLUDING THE KIF1A RESEARCH NETWORK, DIRECT RESEARCH FUNDING, AND OPEN-ACCESS TOOLS FOR DEVELOPMENT, SUCH AS NATURAL HISTORY DATA, DISEASE MODELS, AND BIOMARKERS.
KAND FAMILY AND SCIENTIFIC ENGAGEMENT CONFERENCE - KIF1A.ORG HOSTED THE 2023 KAND FAMILY & SCIENTIFIC ENGAGEMENT CONFERENCE IN NEW YORK CITY, NY FROM AUGUST 3-6, 2023. THESE CONFERENCES BRING TOGETHER KIF1A.ORG COMMUNITY MEMBERS IN ONE SETTING INCLUDING PATIENTS, FAMILIES, SCIENTISTS, CLINICIANS, BIOTECH LEADERS, AND SUPPORTERS. THE LATEST 2023 UPDATES IN RESEARCH AND THERAPEUTIC DEVELOPMENT WERE SHARED AND PATIENTS AND FAMILIES SHARED THEIR PERSONAL STORIES WITH KAND. THIS 4 DAY CONFERENCE ALSO INCLUDED RESEARCH PARTICIPATION FOR 30 KAND PATIENTS AND FAMILIES AND DOUBLED OUR INPERSON KOALA ASSESSMENTS.
OTHER PROGRAMS - GENERAL, COMMUNITY AND FAMILY SUPPORT, CONFERENCE ATTENDANCE AND KOALA TRAVEL REIMBURSEMENT
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Dylan Verden Chief Science Officer | Officer | 40 | $65,744 |
Dominique Lessard Chief Science Officer | Officer | 40 | $41,727 |
Michelle Tao Director Of Strategy | OfficerTrustee | 20 | $0 |
Luke Rosen Board Chair | Trustee | 5 | $0 |
Sally Jackson Director | Trustee | 1 | $0 |
Hans Christinger Board Member | Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Neucyte Neuroscience Scientific Research | 12/30/21 | $100,000 |
Rarebase Scientific Research | 12/30/21 | $50,000 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $206,859 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $206,859 |
Total Program Service Revenue | $0 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $229,470 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $126,432 |
Grants and other assistance to domestic individuals. | $1,848 |
Grants and other assistance to Foreign Orgs/Individuals | $1,676 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $107,469 |
Compensation of current officers, directors, key employees. | $81,760 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $7,582 |
Payroll taxes | $8,784 |
Fees for services: Management | $0 |
Fees for services: Legal | $318 |
Fees for services: Accounting | $5,060 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $31,607 |
Advertising and promotion | $17,875 |
Office expenses | $9,476 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $4,764 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $100,774 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $423,665 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $72,868 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $72,868 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $72,868 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $72,868 |
Over the last fiscal year, Kif1aorg Inc has awarded $52,500 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
COLUMBIA UNIVERSITY PURPOSE: Scientific research | $27,500 |
ALBERT EINSTEIN COLLEGE PURPOSE: Scientific research | $25,000 |